PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 185 filers reported holding PROVENTION BIO INC in Q1 2023. The put-call ratio across all filers is 1.57 and the average weighting 0.4%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sessa Capital IM, L.P. | 8,879,023 | $213,984,454 | 8.12% |
MPM BioImpact LLC | 1,173,809 | $28,288,797 | 7.35% |
Chicago Capital Management, LLC | 274,515 | $6,615,812 | 7.26% |
Vazirani Asset Management LLC | 80,000 | $1,928,000 | 3.64% |
Crabel Capital Management, LLC | 315,391 | $7,601 | 3.37% |
KRYGER CAPITAL Ltd | 754,282 | $18,178,196 | 3.18% |
Western Standard LLC | 109,545 | $2,640,035 | 2.68% |
PSquared Asset Management AG | 766,183 | $18,465,010 | 2.66% |
Kellner Capital, LLC | 75,800 | $1,827 | 2.55% |
Olympiad Research LP | 82,305 | $1,983,551 | 2.31% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 2,925,000 | $70,492,500 | 2.16% |
CHANNEL WEALTH LLC | 131,335 | $3,165,174 | 2.04% |
RAMIUS ADVISORS LLC | 78,356 | $1,888,380 | 1.98% |
WATER ISLAND CAPITAL LLC | 953,407 | $22,977 | 1.86% |
WASHINGTON UNIVERSITY | 291,253 | $7,019,197 | 1.85% |
Versor Investments LP | 570,466 | $13,748,231 | 1.80% |
ALPINE ASSOCIATES MANAGEMENT INC. | 1,364,900 | $32,894,090 | 1.76% |
FNY Investment Advisers, LLC | 57,172 | $1,377 | 1.58% |
683 Capital Management, LLC | 825,000 | $19,882,500 | 1.48% |
Trium Capital LLP | 136,641 | $3,293 | 1.14% |
External links
This page lists PROVENTION BIO INC's shareholders in Q1 2023. To view PROVENTION BIO INC's shareholder history, click here.